By convention, a reference range is usually the middle 95 percent of results from the group it was built from. Most of those people were never followed to see what happened to them. So the range is a statistical interval. It is not a line that separates people who stayed well from people who did not.
Two examples show the gap. Most laboratories print a fasting insulin, the hormone level your pancreas holds while you are not eating, as normal up to about 20 or 25. In the long studies that followed healthy adults for years, the lowest-risk groups sat in the single digits. And for ALT, an enzyme that leaks from irritated liver cells, laboratories print upper limits from about 40 to 65, while the gastroenterology guideline puts a healthy normal near 29 to 33 in men and 19 to 25 in women. The printed limit runs high because the people used to set it included many with liver fat nobody had found.
The reference group reflects the population it came from. One 2022 analysis of national survey data estimated that fewer than 7 percent of US adults had optimal cardiometabolic health across weight, blood pressure, blood sugar, cholesterol and heart disease. The middle of that population is not automatically a goal.
Here is the honest limit. None of this means an in-range result is a problem, or that an out-of-range result is fine. And for most markers, no trial has tested a target inside the normal range, so a better number than normal is a judgment drawn from where risk was lowest in long studies. That is why I read a number three ways: against the lab's range, against what those studies found, and against your own earlier results.
A range is the start of a conversation with your doctor. It is not the end of one.